Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom.
Cancer Res. 2010 Jun 1;70(11):4778-84. doi: 10.1158/0008-5472.CAN-09-4104. Epub 2010 May 18.
Estrogen receptor beta1 (ERbeta1) downregulation occurs in many breast cancers, but the responsible molecular mechanisms remain unclear. Here, we report that levels of ERbeta1 expression are negatively regulated by the microRNA miR-92. Expression analysis in a cohort of primary breast tumors confirmed a significant negative correlation between miR-92 and both ERbeta1 mRNA and protein. Inhibition of miR-92 in MCF-7 cells increased ERbeta1 expression in a dose-dependent manner, whereas miR-92 overexpression led to ERbeta1 downregulation. Reporter constructs containing candidate miR-92 binding sites in the 3'-untranslated region (UTR) of ERbeta1 suggested by bioinformatics analysis confirmed that miR-92 downregulated ERbeta1 via direct targeting of its 3'-UTR. Our results define a potentially important mechanism for downregulation of ERbeta1 expression in breast cancer.
雌激素受体β1(ERβ1)在许多乳腺癌中下调,但负责的分子机制仍不清楚。在这里,我们报告 ERβ1 表达水平受到 microRNA miR-92 的负调控。对一组原发性乳腺癌肿瘤的表达分析证实 miR-92 与 ERβ1 mRNA 和蛋白均呈显著负相关。在 MCF-7 细胞中抑制 miR-92 以剂量依赖的方式增加 ERβ1 的表达,而 miR-92 过表达导致 ERβ1 下调。生物信息学分析提示 ERβ1 3'-UTR 中存在 miR-92 的候选结合位点,报告基因构建证实 miR-92 通过直接靶向其 3'-UTR 下调 ERβ1。我们的结果定义了乳腺癌中 ERβ1 表达下调的一个潜在重要机制。